• post_EOH2015header

  • slide_prepvideos

  • Slideshow_hivhealthreform

  • Slideshow_prep

  • Slideshow_coinfection

Register Today For The Double Bay Double Bike Ride! 

dbd5logo

200 Miles … 2 Bays … 2 Days! CLICK HERE for the website! This year’s Double Bay Double Bike Ride is the culmination of a partnership between Different Spokes San Francisco and Project Inform. The ride is on September 12th and 13th and takes a beautiful —…Read More

IAS2015: No HIV transmissions with suppressed virus

post_2015IAS_sm

by David Evans, Director of Research Advocacy A landmark study, which proved that treating an HIV-positive person with antiretrovirals reduced their risk of passing on HIV to their sex partners, reported final data at the 2015 International AIDS Society conference in Vancouver, finding no HIV transmissions…Read More

IAS2015: Maintenance HIV regimen of rilpivirine and boosted darunavir as effective as three-drug treatment in early results

post_2015IAS_sm

A presentation at the 2015 International AIDS Society conference in Vancouver reported 24-week results comparing a maintenance regimen of rilpivirine (Edurant) + boosted darunavir (Prezista/ritonavir) to a three-drug regimen of a boosted protease inhibitor and two NRTIs. This could offer some people a new treatment option should…Read More

IAS2015: START study confirms the benefits of starting HIV treatment at any CD4 count

post_2015IAS_sm

by Alan McCord, Director of Education A presentation at the 2015 International AIDS Society conference in Vancouver reported additional results from the START (Strategic Timing of Antiretroviral Treatment) Study that showed significant benefits to starting HIV treatment earlier rather than waiting until later to start: a 57%…Read More

Positively Aware publishes special summer issue on PrEP

PA_PrEP_0715_sm

Positively Aware has published a special issue devoted solely to PrEP (Pre-Exposure Prophylaxis). Awareness around PrEP is rapidly increasing around the US, and this issue highlights the personal stories of people on PrEP, the clinical research, ways to access PrEP, and dealing with a difficult provider relationship. Project Inform’s…Read More

IAS2015: Daily dosing and text message reminders associated with PrEP adherence in gay men

post_2015IAS_sm

by David Evans, Director of Research Advocacy Two studies presented at the 8th International AIDS Society conference in Vancouver, Canada offered a look at factors associated with adherence to PrEP in men who have sex with men (MSM). In an oral presentation, researchers with the HPTN…Read More

IAS2015: New NNRTI doravirine as effective as efavirenz in people new to HIV treatment in early study

post_2015IAS_sm

by Alan McCord, Director of Education An oral presentation at the 2015 International AIDS Conference in Vancouver this week reported 24-week results comparing the new NNRTI doravirine to efavirenz. Both drugs were combined with emtricitabine/tenofovir (Truvada). The new NNRTI doravirine may offer benefits compared with the…Read More